|
Sign In to gain access to subscriptions and/or personal tools.
|
Intermittent claudication in the patient with diabetes
Edward B Jude
Tameside & Glossop Diabetes Centre, Tameside General Hospital, Fountain Street, Ashton-under-Lyne, Lancashire, OL6 9RW, UK, edward.jude{at}tgh.nhs.uk
Intermittent claudication (IC) — pain on walking that resolves at rest — is not a trivial complaint but is the first recognisable symptom of peripheral arterial disease (PAD). Diabetes is one of the most important risk factors for PAD and in people with diabetes it tends to be more distal and severe, and more likely to result in gangrene and amputation. Early diagnosis of PAD can reduce the substantial morbidity of the condition, which can culminate in limb loss for some patients. IC in the patient with diabetes can be treated with lifestyle modification, exercise programmes, medical treatment or bypass surgery.
Key Words: intermittent claudication diabetes peripheral arterial disease neuropathy cilostazol.
References
- Leng GC, Lee AJ, Fowkes FG et al. Incidence, natural history and cardiovascular events in symptomatic and asymptomatic peripheral arterial disease in the general population. Int J Epidemiol 1996;25:1171-81.
- Brand FN, Abbot RD, Kannel WB Diabetes, intermittent claudication and risk of cardiovascular events. The Framingham Study. Diabetes 1989;38: 504-09.[Abstract]
- Hendra T. New guidelines for antiplatelet agents. Geriatric Medicine 2003;October:89-96.
- Dormandy JA Natural history of intermittent claudication. Hospital Update 1991;17:314-20.
- Dormandy JA, Rutherford RB Management of peripheral arterial disease (PAD): TASC Working Group. TransAtlantic Inter-Society Consensus (TASC). J Vasc Surg 2000;31(1pt 2): S1-S296.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Jonason T., Ringqvist I. Factors of prognostic importance for subsequent rest pain in patients with intermittent claudication. Acta Med Scand 1985;218:27-33.[Web of Science][Medline]
[Order article via Infotrieve]
- Fowkes FG, Housley E., Cawood EH, Macintyre CC, Ruckley CV, Prescott RJ Edinburgh Artery Study: Prevalence of asymptomatic and symptomatic peripheral arterial disease in the general population. Int J Epidemiol 1991;20:384-92.[Abstract/Free Full Text]
- LoGerfo FW, Gibbons GW Clinical features and treatment of peripheral vascular disease in diabetes mellitus In: KGMM Alberti, P Zimmer, RA DeFronzo, H Keen (eds.). International Textbook of Diabetes Mellitus, Second Edition. Chichester: John Wiley & Sons Ltd, 1997.
- Weitz JI, Byrne J., Clagett GP et al. Diagnosis and treatment of chronic arterial insufficiency of the lower extremities: a critical review. Circulation 1996;94:3026-49.[Free Full Text]
- Schmieder FA, Comerota AJ Intermittent claudication: magnitude of the problem, patient evaluation and therapeutic strategies. Am J Cardiol 2001;87:3D-13D.[Web of Science][Medline]
[Order article via Infotrieve]
- Leng GC, Fowkes FG The Edinburgh Claudication Questionnaire: an improved version of the WHO/Rose Questionnaire for use in epidemiological surveys. J Clin Epidemiol 1992;45:1101-09.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Kannel WB The demographics of claudication and the ageing American population. Vasc Med 1996;1:60-4.[Medline]
[Order article via Infotrieve]
- Olin JW Clinical evaluation and office-based detection of peripheral arterial disease. In: An office-based approach to the diagnosis and treatment of peripheral arterial disease Am J Med `Continuing Medical Education Series,' 1998;10-17.
- Jude EB, Boulton AJM. End stage complications of diabetic neuropathy. Diabetes Reviews 1999;7:395-410.[Web of Science]
- Robless P., Mikhailidis DP, Stansby G. Systematic review of antiplatelet therapy for the prevention of myocardial infarction, stroke or vascular death in patients with peripheral vascular disease. Br J Surg 2001;88: 787-800.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- The Heart Outcomes Prevention Evaluation Study Investigators. Effects of an angiotensin converting enzyme inhibitor, ramipril, on cardiovascular events in high risk patients. New Engl J Med 2000;342:145-53.[Abstract/Free Full Text]
- Heart Protection Study Collaborative Group. MRC/BHF Heart protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 2002;360:7-22.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- British Medical Association and Royal Pharmaceutical Society of Great Britain. British National Formulary 43. March 2002, BMA and RPSGB, London.
- Chapman TM, Goa KL Cilostazol. A review of its use in intermittent claudication. Am J Cardiovas Drugs 2003;3:117-38.[CrossRef]
- Hittel N., Donnelly R. Treating peripheral arterial disease in patients with diabetes. Diabetes Obes Metab 2002;4(suppl 2):S26-S31.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Rendell M., Cariski AT, Hittel N., Zhang P. Cilostazol treatment of claudication in diabetic patients. Curr Med Res Opin 2002;18:479-87.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
The British Journal of Diabetes & Vascular Disease, Vol. 4, No. 4,
238-242 (2004)
DOI: 10.1177/14746514040040040401

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati Twitter What's this?
|
|